Guiding Patients to the right Immunotherapy approach
Transforming early prostate cancer detection through urine liquid biopsy technology
Theranostic patient-centered strategies are often directed against complex and redundant growth signalling networks from surface ligands and receptors through transducers to downstream effector molecules.
Oncologica’s alternative genetic testing approach is to target the cell cycle machinery, which acts as a convergence point for information transduced through upstream signalling networks and therefore represents an exceptionally attractive diagnostic and therapeutic target.
Prof Gareth Williams is the medical and translational lead: directing business strategy, overseeing technical operations and directing all medical aspects of the diagnostic and contract research services.
Read Profile
Dr Marco Loddo is responsible for directing all technical and scientific aspects of the clinical services, contract research activities and administrative/operational matters of the company.
Read Profile
Kitty is responsible for providing advice and implementation on commercial and corporate matters, including the development and application of commercial strategy.
Read Profile
Julian is a consultant clinical genetics at the University Hospitals of Leicester with an honorary professorship in Cancer Studies. He has a specialist interest in familial cancer susceptibility and the implementation of genomic medicine in every day healthcare.
Former: Vice-Provost, Wales Univ. College of Medicine; Prof of Histopathology, Cambridge University; President British Medical Association Royal College of Pathologists President; Learned Society of Wales Fellow; Academy of Medical Sciences Fellow (FMedSci); Honorary Fellow Christ’s College, Cambridge University.
Former: Consultant Medical Oncologist St Vincent’s University Hospital (SVUH); St Luke’s Hospital, National Maternity Hospital; St. Vincent’s Private Hospital; and Blackrock Clinic, Dublin; Member of International Advisory Board of Oneview Ltd. and Oneview Healthcare PLC; Member Director Centre for Colorectal Disease of SVUH.
Former: Consultant Medical Oncologist National Cancer Institute Aviano; Specialist in Oncology, Hematology and Infectious Diseases; Italian Republic Commendatore, awarded by the President of the Republic for scientific merit; co-founder and VP of the Associazione Scientifica Galileo 2001.
Former: Medical Oncologist. Director of: international centre for Precision Oncology, Sanatrix Private Hospital, Rome, and Contract Prof of Medical Oncology, La Sapienza Rome University Consultant of Salem Oncology Center, Houston TX, U.S.A. Member of A.S.C.O. (American Society of Medical Oncology), member of E.S.M.O. (European Society of Medical Oncology).
Former: Consultant Medical Oncologist, Azienda Istituti Ospitalieri, Cremona and Prof of Medical Oncology, Trieste University; Former Prof of Molecular Oncology, Institute of Molecular Medicine, Oxford University. Member of the Board of European Commission for initiative on Breast Cancer.